ERICA CHERRY: Open Payments
NPI 1215618236 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 10 payments from 6 companies in 2025. Trend: 2023 $49 · 2024 $105 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $142 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $78 |
| PFIZER INC. | 2 | $36 |
| ABBVIE INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: NUCALA, NEFFY, NURTEC ODT, UBRELVY, ZEPBOUND, TRELEGY ELLIPTA, TEZSPIRE.
Industry payments across VA — which companies pay providers there.
